TeraMedica inks agreement with I2m

TriMed Staff | | Health Imaging | Diagnostic Imaging
TeraMedica has signed an agreement with Australian-based Intelligent Image Management (I2m) that authorizes I2m to license TeraMedica's Intelligent Image Manager (TI2m) in Australia and South Asia and re-sell TI2m software to healthcare providers in the region.

TI2m is an enterprise archive software system designed to capture data from imaging devices or picture archiving and communication systems (PACS), store the digital images, and make them available for delivery to the point of patient care across the healthcare enterprise.

Additionally, TeraMedica said it has authorized I2m to re-sell TI2m software to individual healthcare providers who may participate in a government managed image management initiative or most likely set up independent data management centers.

TriMed Staff

Related Content

First human X-rays in space to take place during upcoming SpaceX mission
Mycoplasma pneumonia: Experts highlight imaging findings linked to the pediatric diagnosis
AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.